drugset / Trial / NCT02983708

Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem Cells

NCT02983708

RandomizedCrossoverQuadruple-blindTreatment

Summary

The current study describes a randomized, double-blind, cross-over study of intravenous G-CSF followed by infusion with autologous mobilized peripheral blood mononuclear cells (mPBMCs) in children with cerebral palsy (CP) to determine the safety and feasibility of the procedure, as well as the potential efficacy for improving neurological impairment.

Timeline

Start
2011-08
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Granulocyte colony-stimulating factor Protein / enzyme biologic Intravenous
Subject Peripheral blood mononuclear cells Cell therapy Other